Human prolactin receptor variants in breast cancer: Low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma

Cancer Research

Volumn 64, Issue 16, 2004, Pages 5677-5682

  Meng, Jianping ^a   Tsai Morris, Chon Hwa ^a   Dufau, Maria L ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGENIC AGENT; PROLACTIN; PROLACTIN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST CELL; CLINICAL ARTICLE; DNA FINGERPRINTING; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR INTRINSIC ACTIVITY; SOUTHERN BLOTTING; TUMOR GROWTH;

BLOTTING, SOUTHERN; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; HUMANS; PROTEIN ISOFORMS; RECEPTORS, PROLACTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4143066011     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1019     Document Type: Article

References (19)

1. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998;19:225-68.
2. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tomell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Investig 1997;100:2744-51.
3. Bhatavdekar JM, Patel DD, Shah NG, et al. Prolactin as a local growth promoter in patients with breast cancer: GCR1 experience. Eur J Surg Oncol 2000;26:540-7.
4. Peirce SK, Chen WY. Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J Endocrinol 2001;171:R1-4.
5. Bonneterre J, Peyrat JP, Beuscart R, Demaille A. Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer. J Steroid Biochem Mol Biol 1990;37:977-81.
6. Abu-Bedair FA, El-Gamal BA, Ibrahim NA, El-Aaser AA. Hormonal profiles and estrogen receptors in Egyptian female breast cancer patients. Tumori 2000;86:24-9.
7. Ingram DM, Nottage EM, Roberts AN. Prolactin and breast cancer risk. Med J Aust 1990;153:469-73.
8. Bartsch C, Bartsch H, Fuchs U, Lippert TH, Bellmann O, Gupta D. Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors. Cancer (Phila.) 1989;64:426-33.
9. Dowsett M, McGarrick GE, Harris AL, Coombes RC, Smith IE, Jeffcoate SL. Prognostic significance of serum prolactin levels in advanced breast cancer. Br J Cancer 1983;47:763-9.
10. Clevenger CV, Kline JB. Prolactin receptor signal transduction. Lupus 2001;10:706-18.
11. Hu ZZ, Zhuang L, Meng J, Leondires M, Dufau ML. The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP(N). J Clin Endocrinol Metab 1999;84:1153-6.
12. Hu ZZ, Meng J, Dufau ML. Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J Biol Chem 2001;276:41086-94.
13. Hu ZZ, Zhuang L, Meng J, Tsai-Morris CH. Dufau ML. Complex 5′ genomic structure of the human prolactin receptor: multiple alternative exons I and promoter utilization. Endocrinology 2002;143:2139-42.
14. Kline JB, Roehrs H, Clevenger CV. Functional characterization of the intermediate isoform of the human prolactin receptor. J Biol Chem 1999;274:35461-8.
15. Trott JF, Hovey RC, Koduri S, Vonderhaar BK. Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. J Mol Endocrinol 2003;30:31-47.
16. Touraine P, Martini JF, Zafrani B, et al. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab 1998;83:667-74.
17. Laud, K, Gourdou I, Belair L, Peyrat JP, Djiane J. Characterization and modulation of a prolactin receptor mRNA isoform in normal and tumoral human breast tissues. Int J Cancer 2000;85:771-6.
18. Gill S, Peston D, Vonderhaar BK, Shousha S. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. J Clin Pathol (Lond.) 2001;54:956-60.
19. Ormandy CJ, Hall RF, Manning DL, et al. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J Clin Endocrinol Metab 1997;82:3692-9.